IOL CHEMICALS & PHARM. | DIVIS LABORATORIES | IOL CHEMICALS & PHARM./ DIVIS LABORATORIES |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.4 | 71.0 | 18.8% | View Chart |
P/BV | x | 1.5 | 7.7 | 19.8% | View Chart |
Dividend Yield | % | 1.0 | 0.8 | 126.2% |
IOL CHEMICALS & PHARM. DIVIS LABORATORIES |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
DIVIS LABORATORIES Mar-23 |
IOL CHEMICALS & PHARM./ DIVIS LABORATORIES |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 4,641 | 11.6% | |
Low | Rs | 272 | 2,730 | 10.0% | |
Sales per share (Unadj.) | Rs | 377.6 | 292.6 | 129.1% | |
Earnings per share (Unadj.) | Rs | 23.7 | 68.7 | 34.5% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 81.6 | 38.7% | |
Dividends per share (Unadj.) | Rs | 4.00 | 30.00 | 13.3% | |
Avg Dividend yield | % | 1.0 | 0.8 | 121.5% | |
Book value per share (Unadj.) | Rs | 256.8 | 480.9 | 53.4% | |
Shares outstanding (eoy) | m | 58.71 | 265.47 | 22.1% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 12.6 | 8.5% | |
Avg P/E ratio | x | 17.1 | 53.7 | 31.8% | |
P/CF ratio (eoy) | x | 12.8 | 45.2 | 28.4% | |
Price / Book Value ratio | x | 1.6 | 7.7 | 20.5% | |
Dividend payout | % | 16.9 | 43.7 | 38.6% | |
Avg Mkt Cap | Rs m | 23,743 | 978,378 | 2.4% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 9,750 | 17.3% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 77,675 | 28.5% | |
Other income | Rs m | 256 | 3,447 | 7.4% | |
Total revenues | Rs m | 22,427 | 81,122 | 27.6% | |
Gross profit | Rs m | 2,257 | 23,691 | 9.5% | |
Depreciation | Rs m | 462 | 3,432 | 13.5% | |
Interest | Rs m | 165 | 20 | 840.3% | |
Profit before tax | Rs m | 1,887 | 23,686 | 8.0% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 5,453 | 9.1% | |
Profit after tax | Rs m | 1,391 | 18,234 | 7.6% | |
Gross profit margin | % | 10.2 | 30.5 | 33.4% | |
Effective tax rate | % | 26.2 | 23.0 | 114.0% | |
Net profit margin | % | 6.3 | 23.5 | 26.7% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 97,437 | 9.9% | |
Current liabilities | Rs m | 5,025 | 15,331 | 32.8% | |
Net working cap to sales | % | 20.9 | 105.7 | 19.8% | |
Current ratio | x | 1.9 | 6.4 | 30.3% | |
Inventory Days | Days | 43 | 8 | 516.4% | |
Debtors Days | Days | 8 | 842 | 1.0% | |
Net fixed assets | Rs m | 11,017 | 51,128 | 21.5% | |
Share capital | Rs m | 587 | 531 | 110.6% | |
"Free" reserves | Rs m | 14,490 | 127,140 | 11.4% | |
Net worth | Rs m | 15,077 | 127,671 | 11.8% | |
Long term debt | Rs m | 0 | 0 | - | |
Total assets | Rs m | 20,684 | 148,565 | 13.9% | |
Interest coverage | x | 12.5 | 1,209.5 | 1.0% | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 1.1 | 0.5 | 205.0% | |
Return on assets | % | 7.5 | 12.3 | 61.2% | |
Return on equity | % | 9.2 | 14.3 | 64.6% | |
Return on capital | % | 13.6 | 18.6 | 73.3% | |
Exports to sales | % | 26.7 | 85.7 | 31.2% | |
Imports to sales | % | 0 | 19.8 | 0.0% | |
Exports (fob) | Rs m | 5,930 | 66,537 | 8.9% | |
Imports (cif) | Rs m | NA | 15,378 | 0.0% | |
Fx inflow | Rs m | 5,930 | 66,537 | 8.9% | |
Fx outflow | Rs m | 6,052 | 15,715 | 38.5% | |
Net fx | Rs m | -122 | 50,822 | -0.2% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | 24,597 | 5.0% | |
From Investments | Rs m | -1,200 | -27,076 | 4.4% | |
From Financial Activity | Rs m | -41 | -7,972 | 0.5% | |
Net Cashflow | Rs m | -18 | -10,451 | 0.2% |
Indian Promoters | % | 48.2 | 51.9 | 92.8% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 1.7 | 36.9 | 4.6% | |
FIIs | % | 1.4 | 14.7 | 9.5% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 48.1 | 107.8% | |
Shareholders | 130,003 | 347,630 | 37.4% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare IOL CHEMICALS & PHARM. With: SUN PHARMA CIPLA DR. REDDYS LAB ZYDUS LIFESCIENCES MANKIND PHARMA
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | Divis Laboratories | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -0.17% | -1.80% | -0.92% |
1-Month | 8.06% | 5.48% | 1.39% |
1-Year | -1.36% | 13.05% | 51.34% |
3-Year CAGR | -11.55% | -0.96% | 14.50% |
5-Year CAGR | 15.45% | 16.46% | 19.09% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the Divis Laboratories share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of Divis Laboratories the stake stands at 51.9%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of Divis Laboratories.
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
Divis Laboratories paid Rs 30.0, and its dividend payout ratio stood at 43.7%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of Divis Laboratories.
For a sector overview, read our pharmaceuticals sector report.
It was indeed a volatile trading session for Indian share markets today. Benchmark indices swung between gains and losses throughout the day.